ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 78 filers reported holding ITEOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,362 | -8.4% | 33,549 | +10.8% | 0.01% | -18.2% |
| Q2 2023 | $400,920 | +111.4% | 30,281 | +117.3% | 0.01% | +120.0% |
| Q1 2023 | $189,628 | -62.8% | 13,933 | -43.7% | 0.01% | -78.3% |
| Q2 2022 | $510,000 | +6.9% | 24,738 | +66.9% | 0.02% | +4.5% |
| Q1 2022 | $477,000 | -27.8% | 14,824 | -42.5% | 0.02% | -60.7% |
| Q2 2021 | $661,000 | – | 25,778 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |